Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety & Efficacy Study of MRX-7EAT Patch in the Treatment of Pain of the Shoulder

ClinicalTrials.gov ID: NCT01506154

Public ClinicalTrials.gov record NCT01506154. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 7:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Topical Patch in the Treatment of Pain Due to Recent Onset Supraspinatous and/or Subacromial Tendonitis/Bursitis and/or Subdeltoid Bursitis of Shoulder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Pain due to Recent Onset Supraspinatous and/or Subacromial Tendonitis/Bursitis and/or Subdeltoid Bursitis of the Shoulder.

Study identification

NCT ID
NCT01506154
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
MEDRx USA, Inc.
Industry
Enrollment
210 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
14 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2011 (Type not available)
Primary completion
Oct 2012 (Actual)
Completion
Oct 2012 (Actual)
Last update posted
Jan 16, 2018

2011 – 2012

United States locations

U.S. sites
27
U.S. states
16
U.S. cities
26
Facility City State ZIP Site status
Not listed Birmingham Alabama 35216 —
Not listed Scottsdale Arizona 85258 —
Not listed Los Angeles California 90036 —
Not listed San Diego California 92120 —
Not listed Denver Colorado 80239 —
Not listed Clearwater Florida 33761 —
Not listed Coral Gables Florida 33134 —
Not listed Fort Lauderdale Florida 33136 —
Not listed Kissimmee Florida 34741 —
Not listed Lauderdale Lakes Florida 33319 —
Not listed Miami Florida 33155 —
Not listed Orlando Florida 32804 —
Not listed Boise Idaho 83702 —
Not listed Lexington Kentucky 40504 —
Not listed Marrero Louisiana 70072 —
Not listed Southfield Michigan 48034 —
Not listed Raleigh North Carolina 27612 —
Not listed Fargo North Dakota 58103 —
Not listed Zanesville Ohio 43701 —
Not listed Gresham Oregon 97030 —
Not listed Altoona Pennsylvania 16602 —
Not listed Charleston South Carolina 29412 —
Not listed Dallas Texas 75254 —
Not listed El Paso Texas 79902 —
Not listed San Antonio Texas 78207 —
Not listed San Antonio Texas 78229 —
Not listed Temple Texas 76502 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01506154, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 16, 2018 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01506154 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →